Home
About Us
FAQ
Contact Us
Media Tools
ExpertConnect App
MyExpertNet
University Partners
Becoming a Partner
Key Organizations
Search Assistance
Help
Expert Profile
Views:
109
Share
QR code
Edit Profile
Paul Crispen
Clinical Professor, David A. Cofrin Professor Of Urology, Associate Director Of Clinical Research Ufhealth Cancer Center
MD-UROLOGY | COLLEGE-MEDICINE
View:
Select
All (all in one)
Research Terms and Keywords
Publications
Network
Websites
Contact
All
Research
Publications
Network
Websites
Contact
Research Terms & Keywords
Research Terms
Medical Sciences
Industries
Health Care
Research Projects
Ends
Title
11-2029
Salvage Focal Therapy via High Intensity Focused Ultrasound (HIFU) in Radiorecurrent Localized Prostate Cancer (FocalHIFU) (NCT06402357)
Salvage Focal Therapy via High Intensity Focused Ultrasound (HIFU) in Radiorecurrent Localized Prostate Cancer (FocalHIFU) (NCT06402357)
EDAP TECHNOMED
06-2029
Enhancing Connection and Communication with Community-Based Oncology Practices to Improve Cancer Clinical Trial Recruitment: The ECCO Study
Enhancing Connection and Communication with Community-Based Oncology Practices to Improve Cancer Clinical Trial Recruitment: The ECCO Study
LEUKEMIA & LYMPHOMA SO
05-2027
UF Health Cancer Center Support Grant
UF Health Cancer Center Support Grant
NATL INST OF HLTH NC
11-2026
PHASE III RANDOMIZED ADJUVANT STUDY OF MK-3475 (PEMBROLIZUMAB) IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA (AMBASSADOR) VERSUS OBSERVATION
PHASE III RANDOMIZED ADJUVANT STUDY OF MK-3475 (PEMBROLIZUMAB) IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA (AMBASSADOR) VERSUS OBSERVATION
ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY
11-2026
PHASE III RANDOMIZED ADJUVANT STUDY OF MK-3475 (PEMBROLIZUMAB) IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA (AMBASSADOR) VERSUS OBSERVATION
PHASE III RANDOMIZED ADJUVANT STUDY OF MK-3475 (PEMBROLIZUMAB) IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA (AMBASSADOR) VERSUS OBSERVATION
NATL INST OF HLTH NC
11-2026
A PHASE II STUDY OF DOSE-DENSE GEMCITABINE PLUS CISPLATIN (DDGC) IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER WITH BLADDER PRESERVATION FOR THOSE PATIENTS WHOSE TUMORS HARBOR DELETERIOUS DNA DAMAGE RESPONSE (DDR) GENE ALTERATIONS
A PHASE II STUDY OF DOSE-DENSE GEMCITABINE PLUS CISPLATIN (DDGC) IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER WITH BLADDER PRESERVATION FOR THOSE PATIENTS WHOSE TUMORS HARBOR DELETERIOUS DNA DAMAGE RESPONSE (DDR) GENE ALTERATIONS
ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY
11-2026
A PHASE II STUDY OF DOSE-DENSE GEMCITABINE PLUS CISPLATIN (DDGC) IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER WITH BLADDER PRESERVATION FOR THOSE PATIENTS WHOSE TUMORS HARBOR DELETERIOUS DNA DAMAGE RESPONSE (DDR) GENE ALTERATIONS
A PHASE II STUDY OF DOSE-DENSE GEMCITABINE PLUS CISPLATIN (DDGC) IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER WITH BLADDER PRESERVATION FOR THOSE PATIENTS WHOSE TUMORS HARBOR DELETERIOUS DNA DAMAGE RESPONSE (DDR) GENE ALTERATIONS
NATL INST OF HLTH NC
10-2026
PD-INHIBITOR (NIVOLUMAB) AND IPILIMUMAB FOLLOWED BY NIVOLUMAB VS. VEGF TKI CABOZANTINIB WITH NIVOLUMAB: A PHASE III TRIAL IN METASTATIC UNTREATED RENAL CELL CANCER [PDIGREE]
PD-INHIBITOR (NIVOLUMAB) AND IPILIMUMAB FOLLOWED BY NIVOLUMAB VS. VEGF TKI CABOZANTINIB WITH NIVOLUMAB: A PHASE III TRIAL IN METASTATIC UNTREATED RENAL CELL CANCER [PDIGREE]
NATL INST OF HLTH NC
10-2026
PD-INHIBITOR (NIVOLUMAB) AND IPILIMUMAB FOLLOWED BY NIVOLUMAB VS. VEGF TKI CABOZANTINIB WITH NIVOLUMAB: A PHASE III TRIAL IN METASTATIC UNTREATED RENAL CELL CANCER [PDIGREE]
PD-INHIBITOR (NIVOLUMAB) AND IPILIMUMAB FOLLOWED BY NIVOLUMAB VS. VEGF TKI CABOZANTINIB WITH NIVOLUMAB: A PHASE III TRIAL IN METASTATIC UNTREATED RENAL CELL CANCER [PDIGREE]
NRG ONCOLOGY FOU
06-2026
Florida Partnership for Adding Social Context to Address Cancer Survivorship Outcomes (ASCENT)
Florida Partnership for Adding Social Context to Address Cancer Survivorship Outcomes (ASCENT)
FL DEPT OF HLT
05-2026
PHASE II TRIAL OF INTRAVESICAL GEMCITABINE AND MK-3475 (PEMBROLIZUMAB) IN THE TREATMENT OF PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
PHASE II TRIAL OF INTRAVESICAL GEMCITABINE AND MK-3475 (PEMBROLIZUMAB) IN THE TREATMENT OF PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
NATL INST OF HLTH NC
04-2026
Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)
Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)
NATL INST OF HLTH NC
04-2026
Phase III Study of Daratumumab/rHuPH20 (NSC- 810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients with Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Stu
Phase III Study of Daratumumab/rHuPH20 (NSC- 810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients with Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Stu
NATL INST OF HLTH NC
02-2026
A Phase III Randomized, Double-Blind Study of Maintenance Therapy with CC-5013 (NSC # 703813, IND # 70116) or Placebo Following Autologous Stem Cell Transplantation for Multiple Myeloma
A Phase III Randomized, Double-Blind Study of Maintenance Therapy with CC-5013 (NSC # 703813, IND # 70116) or Placebo Following Autologous Stem Cell Transplantation for Multiple Myeloma
NATL INST OF HLTH NC
02-2026
NRG Affiliate Master-Federal
NRG Affiliate Master-Federal
NATL INST OF HLTH NC
02-2026
A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-Na?ve High-Grade Non-Muscle Invasive Bladder Cancer
A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-Na?ve High-Grade Non-Muscle Invasive Bladder Cancer
NATL INST OF HLTH NC
02-2026
A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-Na?ve High-Grade Non-Muscle Invasive Bladder Cancer
A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-Na?ve High-Grade Non-Muscle Invasive Bladder Cancer
SOUTHWEST ONCOLOGY GROU
02-2025
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer (Study SWOG/NRG 1806)
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer (Study SWOG/NRG 1806)
NATL INST OF HLTH NC
02-2025
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer (Study SWOG/NRG 1806)
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer (Study SWOG/NRG 1806)
NRG ONCOLOGY FOU
08-2024
ASCO Screening and Enrollment Qualitative Study
ASCO Screening and Enrollment Qualitative Study
AMER SOC FOR CLINICAL ONCOLOG
02-2022
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
NATL INST OF HLTH NC
02-2022
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
NRG ONCOLOGY FOU
03-2021
Dissecting the Mechanisms of Tumor-Induced Tolerance and Immune Suppression
Dissecting the Mechanisms of Tumor-Induced Tolerance and Immune Suppression
FL DEPT OF HLTH BIOMED RES PGM/J&E KIN
04-2020
NCTN High Performing Site Initiative (HPSI)
NCTN High Performing Site Initiative (HPSI)
NATL INST OF HLTH NC
04-2020
NCTN High Performing Site Initiative (HPSI)
NCTN High Performing Site Initiative (HPSI)
PPD DEVELOPMEN
01-2020
NCTN High Performing Site Initiative (HPSI)
NCTN High Performing Site Initiative (HPSI)
NATL INST OF HLTH NC
01-2020
NCTN High Performing Site Initiative (HPSI)
NCTN High Performing Site Initiative (HPSI)
PPD DEVELOPMEN
02-2019
NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER
NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER
NATL INST OF HLTH NC
02-2019
NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER
NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER
NRG ONCOLOGY FOU
Publications
OpenAlex
Search Engines
Last updated on 1/31/26. See our
OpenAlex FAQ
for more about this data.
Search Google Scholar for Paul Crispen
OpenAlex Works Search
Co-Investigator Network
Dietmar Siemann
Professor; Associate Director For Education and Training, Ufhci
University of Florida
Md-Radiation Oncology, College-Medicine
siemadw@ufl.edu
Inactive Expert
Carmen Allegra
Professor Emeritus/Courtesy Faculty
University of Florida
Md-Hematology-Oncology, College-Medicine
Rolf Renne
Professor
University of Florida
Md-Molecular Gentcs - Microbio, College-Medicine
rrenne@ufl.edu
Thomas George
Associateprofessor - Physician
University of Florida
Md-Hematology/Oncology, College-Medicine
tgeorge@ufl.edu
Lizi Wu
Ph.D.
University of Florida
Md-Molecular Gentcs / Microbio, College-Medicine
lzwu@ufl.edu
Sergei Kusmartsev
Assistant Professor
University of Florida
Urology, University Of Florida, College Of Medicine
s.kusmartsev@urology.ufl.edu
Stephanie Staras
Professor and Associate Chair Of Faculty Development
University of Florida
Md-Hobi-General, College-Medicine
sstaras@mail.ufl.edu
Inactive Expert
John Hiemenz
Professor
University of Florida
Md-Hematology-Oncology, College-Medicine
Christian Jobin
Professor Of Medicine; Principal Investigator
University of Florida
Md-Gastroenterology, College-Medicine
cjobin@ufl.edu
Duane Mitchell
Director - Uf Clinical and Translational Science Institute; Assistant Vice President For Research - University Of Florida; Associate Dean - Uf College Of Medicine
University of Florida
Md-Neurological Surgery, College-Medicine
duane.mitchell@neurosurgery.ufl.edu
Elias Sayour
Stop Children's Cancer/Bonnie R. Freeman Professor For Pediatric Oncology Research; Assistant Dean
University of Florida
Md-Neurological Surgery, College-Medicine
elias.sayour@neurosurgery.ufl.edu
Ramzi Salloum
Professor and Associate Chair For Research; Division Chief For Implementation Science
University of Florida
Md-Hobi-General, College-Medicine
rsalloum@ufl.edu
Inactive Expert
Paul Dominguez
Phd
University of Florida
Md-Urology, College-Medicine
Carma Bylund-Lincoln
Professor and Associate Chair Of Education
University of Florida
Md-Hobi-General, College-Medicine
carma.bylund@ufl.edu
Ji-Hyun Lee
Professor & Associate Director For Cancer Quantitative Sciences
University of Florida
Phhp-Com Biostatistics, Phhp-Com Integrated Programs
jihyun.lee@ufl.edu
Weizhou Zhang
Professor, Vice Chair Of Research
University of Florida
Md-Pathology-General, College-Medicine
zhangw@ufl.edu
Melissa Vilaro
Ast Prof
University of Florida
Ag-Fam Youth - Comm Sci, College- Agricul - Nat Res
mgraveley@ufl.edu
Inactive Expert
Jonathan Chatzkel
Assistant Professor
University of Florida
Md-Hematology-Oncology, College-Medicine
Danielle Jake-Schoffman
Aso Prof
University of Florida
Hh-Heb-Administration, College-Hlth-Human Performance
djakeschoffman@ufl.edu
XiangYang Lou
Research Professor
University of Florida
Phhp-Com Biostatistics, Phhp-Com Integrated Programs
xlou@ufl.edu
Inactive Expert
Brian Ramnaraign
Assistant Professor
University of Florida
Md-Urology, College-Medicine
Dejana Braithwaite
Professor and Division Chief, Population Health Sciences, Department Of Surgery
University of Florida
Md-Surg-Population Health Sci, College-Medicine
dbraithwaite@ufl.edu
Megan Gregory
Associate Professor
University of Florida
Md-Hobi-Biomed Informatics, College-Medicine
megan.gregory@ufl.edu
Padraic O'Malley
Associate Professor
University of Florida
Md-Urology, College-Medicine
p.omalley@ufl.edu
Steven Madore
Assoc Director For Science
University of Florida
Re-Icbr-Aux&Hsc, Uf Research
smadore@ufl.edu
Tuo Lin
Research Assistant Professor
University of Florida
Phhp-Com Biostatistics, Phhp-Com Integrated Programs
tuolin@ufl.edu
Tarik Benidir
Clinical Assistant Professor
University of Florida
Md-Urology, College-Medicine
tarik.benidir@ufl.edu
Sulma Mohammed
Professor
University of Florida
Vm-Sacs, College-Veterinary Med
smohammed2@ufl.edu
Lucy Guerra
Professor
University of Florida
Md-Internal Medicine, College-Medicine
lucyguerra@ufl.edu
Daniel Araujo
Clin Aso Prof
University of Florida
Md-Hematology-Oncology, College-Medicine
daniel.araujo@ufl.edu
Francis Dalisay
Aso Prof
University of Florida
Cjc-Public Relations-General, College-Journalism - Communica
f.dalisay@ufl.edu
Expertnet Author Network
Experts within Florida Expertnet that have co-authored works with Paul Crispen.
Jose Principe
Dis Professor
University of Florida
Eg-Electrical - Computer Eng, College-Engineering
principe@cnel.ufl.edu
Works Co-Authored: 1132
Roger Fillingim
Associate Dean Of Planning and Institutional Effectiveness, Distinguished Professor, Director Of Price
University of Florida
Dn-Community Dentistry, College-Dentistry
rfilling@ufl.edu
Works Co-Authored: 847
Margaret Wallace
Professor
University of Florida
Dept. Molecular Genetics & Microbio, College Of Medicine
peggyw@ufl.edu
Works Co-Authored: 366
Samsun Lampotang
Joachim S. Gravenstein Professorship Of Anesthesiology; Director, Cssalt; Joint Professor Of Urology
University of Florida
Md-Anesthesiology-General, College-Medicine
slampotang@anest.ufl.edu
Works Co-Authored: 140
Sandra Russo
Scholar
University of Florida
Ip-International Center-Gen, International Center
srusso@ufic.ufl.edu
Works Co-Authored: 22
Thomas George
Associateprofessor - Physician
University of Florida
Md-Hematology/Oncology, College-Medicine
tgeorge@ufl.edu
Works Co-Authored: 627
Sergei Kusmartsev
Assistant Professor
University of Florida
Urology, University Of Florida, College Of Medicine
s.kusmartsev@urology.ufl.edu
Works Co-Authored: 88
Stephanie Staras
Professor and Associate Chair Of Faculty Development
University of Florida
Md-Hobi-General, College-Medicine
sstaras@mail.ufl.edu
Works Co-Authored: 72
Inactive Expert
Robert Zlotecki
Professor & Vice Chairman
University of Florida
Md-Radiation Oncology, College-Medicine
Works Co-Authored: 99
Li-Ming Su
Professor Of Urology
University of Florida
Md-Urology, College-Medicine
sulm@urology.ufl.edu
Works Co-Authored: 156
Long Dang
Md
University of Florida
Ph-Medicinal Chemistry, College-Pharmacy
danglh@ufl.edu
Works Co-Authored: 49
Steven Hughes
Edward M. Copeland, III Md Professor and Chief, Surgical Oncology
University of Florida
Md-Surgery-Surgonc-Pbs, College-Medicine
steven.hughes@surgery.ufl.edu
Works Co-Authored: 413
Gregory Murad
Program Director & Clinical Professsor
University of Florida
Md-Neurological Surgery, College-Medicine
murad@neurosurgery.ufl.edu
Works Co-Authored: 54
Patrick Tighe
Executive Director, Quality and Patient Safety Initiative (Qpsi)
University of Florida
Md-Anesthesiology-General, College-Medicine
ptighe@ufl.edu
Works Co-Authored: 182
Inactive Expert
Hari Parvataneni
Professor Of Orthopaedic Surgery
University of Florida
Md-Orthopaedics - Rehab, College-Medicine
Works Co-Authored: 48
Parisa Rashidi
Professor
University of Florida
Eg-Biomedical Engineering, College-Engineering
parisa.rashidi@bme.ufl.edu
Works Co-Authored: 193
Yi Guo
Associate Professor & Associate Chair For Data Science; Division Chief, Biomedical Informatics and Data Science
University of Florida
Md-Hobi-General, College-Medicine
yiguo@ufl.edu
Works Co-Authored: 403
Ramzi Salloum
Professor and Associate Chair For Research; Division Chief For Implementation Science
University of Florida
Md-Hobi-General, College-Medicine
rsalloum@ufl.edu
Works Co-Authored: 295
Hans Ghayee
Professor; Va Section Chief
University of Florida
Md-Endocrinology, College-Medicine
hans.ghayee@medicine.ufl.edu
Works Co-Authored: 110
Inactive Expert
Paul Dominguez
Phd
University of Florida
Md-Urology, College-Medicine
Works Co-Authored: 27
Inactive Expert
Chancellor Gray
Division Chief, Adult Arthroplasty and Joint Reconstruction; Associate Professor
University of Florida
Md-Orthopaedics - Rehab, College-Medicine
Works Co-Authored: 24
Terrie Vasilopoulos
Associate Professor Of Anesthesiology and Orthopaedic Surgery & Sports Medicine
University of Florida
Md-Anesthesiology-General, College-Medicine
tvasilopoulos@ufl.edu
Works Co-Authored: 193
Joseph Grajo
Chief & Clin Prof
University of Florida
Md-Radiolgy-Body Imaging, College-Medicine
grajjr@radiology.ufl.edu
Works Co-Authored: 109
William Donelan
Research Associate Scientist
University of Florida
Md-Uro-Prostate Disease Center, College-Medicine
william.donelan@urology.ufl.edu
Works Co-Authored: 36
Dennie Jones
Professor
University of Florida
Md-Hematology-Oncology, College-Medicine
dvjonesii@ufl.edu
Works Co-Authored: 92
Cameron Smith
Associate Professor Of Anesthesiology; Clinical Director Of Research, Division Of Acute Pain Medicine
University of Florida
Md-Anest-Acute Pain Service, College-Medicine
csmith@anest.ufl.edu
Works Co-Authored: 49
Ji-Hyun Lee
Professor & Associate Director For Cancer Quantitative Sciences
University of Florida
Phhp-Com Biostatistics, Phhp-Com Integrated Programs
jihyun.lee@ufl.edu
Works Co-Authored: 1045
Kathryn Hitchcock
Physician, Interim Chair Of Radiation Oncology, & Senior Leader For Professional Development
University of Florida
Md-Radiation Oncology, College-Medicine
hitcka@shands.ufl.edu
Works Co-Authored: 107
Inactive Expert
Jonathan Chatzkel
Assistant Professor
University of Florida
Md-Hematology-Oncology, College-Medicine
Works Co-Authored: 33
Inactive Expert
Brian Ramnaraign
Assistant Professor
University of Florida
Md-Urology, College-Medicine
Works Co-Authored: 68
Sara Falzarano
Clinical Associate Professor
University of Florida
Md-Pathology-General, College-Medicine
sfalzarano@ufl.edu
Works Co-Authored: 95
Russell Terry
Assistant Professor Of Urology
University of Florida
Md-Urology, College-Medicine
rsterry@ufl.edu
Works Co-Authored: 64
Inactive Expert
Wayne Brisbane
Assistant Professor
University of Florida
Md-Urology, College-Medicine
Works Co-Authored: 14
Inactive Expert
Musacide Ordulu Sahin
University of Florida
Md-Pathology-General, College-Medicine
Works Co-Authored: 6
Arkaprava Roy
Assistant Professor
University of Florida
Phhp-Com Biostatistics, Phhp-Com Integrated Programs
arkaprava.roy@ufl.edu
Works Co-Authored: 13
Padraic O'Malley
Associate Professor
University of Florida
Md-Urology, College-Medicine
p.omalley@ufl.edu
Works Co-Authored: 35
Ibrahim Nassour
Assistant Professor
University of Florida
Md-Surgery-Surgonc-Pbs, College-Medicine
ibrahimnassour@ufl.edu
Works Co-Authored: 33
Alan Pollack
University of Miami
Radiation Oncology, Medical
apollack@miami.edu
Works Co-Authored: 709
Websites
ORCID 0000-0002-2557-8605
OpenAlex Works Search
Search Google Scholar for Paul Crispen
Contact Information
paul.crispen@urology.ufl.edu
3522736818
PO Box 100247 GAINESVILLE, FL 32610
Profile QR code
What is this?
Keyword Search
Please enter valid search criteria.
Search
Centers
Experts
Projects
Publications
Speakers
Stories
Technologies
Videos
University
All Universities
Florida A&M University
Florida Atlantic University
Florida Gulf Coast University
Florida Institute of Technology
Florida International University
Florida State University
University of Central Florida
University of Florida
University of Miami
University of North Florida
University of South Florida
University of West Florida
Browse by STEM
Biotechnology
Computer Science
Energy
Engineering
Environmental Sciences
Information Science
Life Sciences
Mathematics
Medical Sciences
Military Sciences
Natural Sciences
Physical Sciences
Plant Sciences
Science
Space Sciences
Technology
Transportation
